The global Nocturnal Enuresis Medication market was valued at 4158 million in 2024 and is projected to reach US$ 5323 million by 2032, at a CAGR of 3.7% during the forecast period.
Nocturnal enuresis medication refers to pharmaceutical drugs or medications prescribed to individuals who experience nocturnal enuresis, commonly known as bedwetting. Nocturnal enuresis is the involuntary release of urine during sleep, which can affect both children and adults. Medications for this condition are typically prescribed when other treatment approaches, such as behavioral therapies, have proven ineffective, and when the bedwetting significantly impacts an individual"s quality of life.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Nocturnal Enuresis Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Nocturnal Enuresis Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturnal Enuresis Medication. This report contains market size and forecasts of Nocturnal Enuresis Medication in global, including the following market information:
Global Nocturnal Enuresis Medication market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Nocturnal Enuresis Medication companies in 2024 (%)
Total Market by Segment:
Global Nocturnal Enuresis Medication market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Nocturnal Enuresis Medication market segment percentages, by Type, 2024 (%)
Desmopressin(DDAVP)
Tofranil
Others
Global Nocturnal Enuresis Medication market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Nocturnal Enuresis Medication market segment percentages, by Application, 2024 (%)
Hospital
Specialist Clinic
Others
Global Nocturnal Enuresis Medication market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Nocturnal Enuresis Medication market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nocturnal Enuresis Medication revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Nocturnal Enuresis Medication revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nocturnal Enuresis Medication, market overview.
Chapter 2: Global Nocturnal Enuresis Medication market size in revenue.
Chapter 3: Detailed analysis of Nocturnal Enuresis Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nocturnal Enuresis Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nocturnal Enuresis Medication Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Nocturnal Enuresis Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nocturnal Enuresis Medication Overall Market Size
2.1 Global Nocturnal Enuresis Medication Market Size: 2024 VS 2032
2.2 Global Nocturnal Enuresis Medication Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nocturnal Enuresis Medication Players in Global Market
3.2 Top Global Nocturnal Enuresis Medication Companies Ranked by Revenue
3.3 Global Nocturnal Enuresis Medication Revenue by Companies
3.4 Top 3 and Top 5 Nocturnal Enuresis Medication Companies in Global Market, by Revenue in 2024
3.5 Global Companies Nocturnal Enuresis Medication Product Type
3.6 Tier 1, Tier 2, and Tier 3 Nocturnal Enuresis Medication Players in Global Market
3.6.1 List of Global Tier 1 Nocturnal Enuresis Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Nocturnal Enuresis Medication Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Nocturnal Enuresis Medication Market Size Markets, 2024 & 2032
4.1.2 Desmopressin(DDAVP)
4.1.3 Tofranil
4.1.4 Others
4.2 Segmentation by Type - Global Nocturnal Enuresis Medication Revenue & Forecasts
4.2.1 Segmentation by Type - Global Nocturnal Enuresis Medication Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Nocturnal Enuresis Medication Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Nocturnal Enuresis Medication Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Specialist Clinic
5.1.4 Others
5.2 Segmentation by Application - Global Nocturnal Enuresis Medication Revenue & Forecasts
5.2.1 Segmentation by Application - Global Nocturnal Enuresis Medication Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Nocturnal Enuresis Medication Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Nocturnal Enuresis Medication Market Size, 2024 & 2032
6.2 By Region - Global Nocturnal Enuresis Medication Revenue & Forecasts
6.2.1 By Region - Global Nocturnal Enuresis Medication Revenue, 2020-2025
6.2.2 By Region - Global Nocturnal Enuresis Medication Revenue, 2026-2032
6.2.3 By Region - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Nocturnal Enuresis Medication Revenue, 2020-2032
6.3.2 United States Nocturnal Enuresis Medication Market Size, 2020-2032
6.3.3 Canada Nocturnal Enuresis Medication Market Size, 2020-2032
6.3.4 Mexico Nocturnal Enuresis Medication Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Nocturnal Enuresis Medication Revenue, 2020-2032
6.4.2 Germany Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.3 France Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.4 U.K. Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.5 Italy Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.6 Russia Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.7 Nordic Countries Nocturnal Enuresis Medication Market Size, 2020-2032
6.4.8 Benelux Nocturnal Enuresis Medication Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Nocturnal Enuresis Medication Revenue, 2020-2032
6.5.2 China Nocturnal Enuresis Medication Market Size, 2020-2032
6.5.3 Japan Nocturnal Enuresis Medication Market Size, 2020-2032
6.5.4 South Korea Nocturnal Enuresis Medication Market Size, 2020-2032
6.5.5 Southeast Asia Nocturnal Enuresis Medication Market Size, 2020-2032
6.5.6 India Nocturnal Enuresis Medication Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Nocturnal Enuresis Medication Revenue, 2020-2032
6.6.2 Brazil Nocturnal Enuresis Medication Market Size, 2020-2032
6.6.3 Argentina Nocturnal Enuresis Medication Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nocturnal Enuresis Medication Revenue, 2020-2032
6.7.2 Turkey Nocturnal Enuresis Medication Market Size, 2020-2032
6.7.3 Israel Nocturnal Enuresis Medication Market Size, 2020-2032
6.7.4 Saudi Arabia Nocturnal Enuresis Medication Market Size, 2020-2032
6.7.5 UAE Nocturnal Enuresis Medication Market Size, 2020-2032
7 Companies Profiles
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Nocturnal Enuresis Medication Major Product Offerings
7.1.4 Allergan Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.1.5 Allergan Key News & Latest Developments
7.2 Ferring Pharmaceuticals, Inc.
7.2.1 Ferring Pharmaceuticals, Inc. Corporate Summary
7.2.2 Ferring Pharmaceuticals, Inc. Business Overview
7.2.3 Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Major Product Offerings
7.2.4 Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.2.5 Ferring Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporate Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Nocturnal Enuresis Medication Major Product Offerings
7.3.4 Pfizer Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Janssen Pharmaceuticals, Inc.
7.4.1 Janssen Pharmaceuticals, Inc. Corporate Summary
7.4.2 Janssen Pharmaceuticals, Inc. Business Overview
7.4.3 Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Major Product Offerings
7.4.4 Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.4.5 Janssen Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Urovant Sciences, Inc.
7.5.1 Urovant Sciences, Inc. Corporate Summary
7.5.2 Urovant Sciences, Inc. Business Overview
7.5.3 Urovant Sciences, Inc. Nocturnal Enuresis Medication Major Product Offerings
7.5.4 Urovant Sciences, Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.5.5 Urovant Sciences, Inc. Key News & Latest Developments
7.6 Astellas Pharma US, Inc.
7.6.1 Astellas Pharma US, Inc. Corporate Summary
7.6.2 Astellas Pharma US, Inc. Business Overview
7.6.3 Astellas Pharma US, Inc. Nocturnal Enuresis Medication Major Product Offerings
7.6.4 Astellas Pharma US, Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.6.5 Astellas Pharma US, Inc. Key News & Latest Developments
7.7 Bayer Corp
7.7.1 Bayer Corp Corporate Summary
7.7.2 Bayer Corp Business Overview
7.7.3 Bayer Corp Nocturnal Enuresis Medication Major Product Offerings
7.7.4 Bayer Corp Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.7.5 Bayer Corp Key News & Latest Developments
7.8 Mallinckrodt, Inc.
7.8.1 Mallinckrodt, Inc. Corporate Summary
7.8.2 Mallinckrodt, Inc. Business Overview
7.8.3 Mallinckrodt, Inc. Nocturnal Enuresis Medication Major Product Offerings
7.8.4 Mallinckrodt, Inc. Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.8.5 Mallinckrodt, Inc. Key News & Latest Developments
7.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
7.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Corporate Summary
7.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
7.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Major Product Offerings
7.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Key News & Latest Developments
7.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
7.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Corporate Summary
7.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
7.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Major Product Offerings
7.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Key News & Latest Developments
7.11 Beijing Zizhu Pharmaceutical Co., Ltd
7.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Corporate Summary
7.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
7.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Major Product Offerings
7.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Key News & Latest Developments
7.12 Shanghai Pharmaceutical Group
7.12.1 Shanghai Pharmaceutical Group Corporate Summary
7.12.2 Shanghai Pharmaceutical Group Business Overview
7.12.3 Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Major Product Offerings
7.12.4 Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Revenue in Global Market (2020-2025)
7.12.5 Shanghai Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nocturnal Enuresis Medication Market Opportunities & Trends in Global Market
Table 2. Nocturnal Enuresis Medication Market Drivers in Global Market
Table 3. Nocturnal Enuresis Medication Market Restraints in Global Market
Table 4. Key Players of Nocturnal Enuresis Medication in Global Market
Table 5. Top Nocturnal Enuresis Medication Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Nocturnal Enuresis Medication Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Nocturnal Enuresis Medication Revenue Share by Companies, 2020-2025
Table 8. Global Companies Nocturnal Enuresis Medication Product Type
Table 9. List of Global Tier 1 Nocturnal Enuresis Medication Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nocturnal Enuresis Medication Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Nocturnal Enuresis Medication Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Nocturnal Enuresis Medication Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application– Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 17. By Region– Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Nocturnal Enuresis Medication Revenue, (US$, Mn), 2026-2032
Table 30. Allergan Corporate Summary
Table 31. Allergan Nocturnal Enuresis Medication Product Offerings
Table 32. Allergan Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 33. Allergan Key News & Latest Developments
Table 34. Ferring Pharmaceuticals, Inc. Corporate Summary
Table 35. Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Product Offerings
Table 36. Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 37. Ferring Pharmaceuticals, Inc. Key News & Latest Developments
Table 38. Pfizer Inc. Corporate Summary
Table 39. Pfizer Inc. Nocturnal Enuresis Medication Product Offerings
Table 40. Pfizer Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 41. Pfizer Inc. Key News & Latest Developments
Table 42. Janssen Pharmaceuticals, Inc. Corporate Summary
Table 43. Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Product Offerings
Table 44. Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 45. Janssen Pharmaceuticals, Inc. Key News & Latest Developments
Table 46. Urovant Sciences, Inc. Corporate Summary
Table 47. Urovant Sciences, Inc. Nocturnal Enuresis Medication Product Offerings
Table 48. Urovant Sciences, Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 49. Urovant Sciences, Inc. Key News & Latest Developments
Table 50. Astellas Pharma US, Inc. Corporate Summary
Table 51. Astellas Pharma US, Inc. Nocturnal Enuresis Medication Product Offerings
Table 52. Astellas Pharma US, Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 53. Astellas Pharma US, Inc. Key News & Latest Developments
Table 54. Bayer Corp Corporate Summary
Table 55. Bayer Corp Nocturnal Enuresis Medication Product Offerings
Table 56. Bayer Corp Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 57. Bayer Corp Key News & Latest Developments
Table 58. Mallinckrodt, Inc. Corporate Summary
Table 59. Mallinckrodt, Inc. Nocturnal Enuresis Medication Product Offerings
Table 60. Mallinckrodt, Inc. Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 61. Mallinckrodt, Inc. Key News & Latest Developments
Table 62. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Corporate Summary
Table 63. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Product Offerings
Table 64. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 65. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Key News & Latest Developments
Table 66. Guangdong Xianqiang Pharmaceutical Co., Ltd Corporate Summary
Table 67. Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Product Offerings
Table 68. Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 69. Guangdong Xianqiang Pharmaceutical Co., Ltd Key News & Latest Developments
Table 70. Beijing Zizhu Pharmaceutical Co., Ltd Corporate Summary
Table 71. Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Product Offerings
Table 72. Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 73. Beijing Zizhu Pharmaceutical Co., Ltd Key News & Latest Developments
Table 74. Shanghai Pharmaceutical Group Corporate Summary
Table 75. Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Product Offerings
Table 76. Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Revenue (US$, Mn) & (2020-2025)
Table 77. Shanghai Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Nocturnal Enuresis Medication Product Picture
Figure 2. Nocturnal Enuresis Medication Segment by Type in 2024
Figure 3. Nocturnal Enuresis Medication Segment by Application in 2024
Figure 4. Global Nocturnal Enuresis Medication Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Nocturnal Enuresis Medication Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Nocturnal Enuresis Medication Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Nocturnal Enuresis Medication Revenue in 2024
Figure 9. Segmentation by Type – Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application – Global Nocturnal Enuresis Medication Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 13. By Region - Global Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 14. By Country - North America Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 15. United States Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 19. Germany Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 20. France Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 27. China Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 31. India Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 33. Brazil Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Nocturnal Enuresis Medication Revenue Market Share, 2020-2032
Figure 36. Turkey Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Nocturnal Enuresis Medication Revenue, (US$, Mn), 2020-2032
Figure 40. Allergan Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Ferring Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Pfizer Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Janssen Pharmaceuticals, Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Urovant Sciences, Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Astellas Pharma US, Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Bayer Corp Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Mallinckrodt, Inc. Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Guangdong Xianqiang Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Beijing Zizhu Pharmaceutical Co., Ltd Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Shanghai Pharmaceutical Group Nocturnal Enuresis Medication Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
